These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18098321)

  • 1. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
    Bellentani S; Dalle Grave R; Suppini A; Marchesini G;
    Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lifestyle changes in non-alcoholic fatty liver disease.
    Centis E; Marzocchi R; Di Domizio S; Ciaravella MF; Marchesini G
    Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.
    Cortez-Pinto H; Machado M
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):217-31. PubMed ID: 19072357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.
    Moscatiello S; Di Luzio R; Bugianesi E; Suppini A; Hickman IJ; Di Domizio S; Dalle Grave R; Marchesini G
    Obesity (Silver Spring); 2011 Apr; 19(4):763-70. PubMed ID: 20966900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the treatment of fatty liver disease associated with the metabolic syndrome.
    Marchesini G; Natale S; Manini R; Agostini F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():37-9. PubMed ID: 16225470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.
    Johnson NA; George J
    Hepatology; 2010 Jul; 52(1):370-81. PubMed ID: 20578153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease and low-carbohydrate diets.
    York LW; Puthalapattu S; Wu GY
    Annu Rev Nutr; 2009; 29():365-79. PubMed ID: 19575599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of nonalcoholic fatty liver disease.
    Targher G; Bellis A; Fornengo P; Ciaravella F; Pichiri I; Cavallo Perin P; Trimarco B; Marchesini G
    Dig Liver Dis; 2010 May; 42(5):331-40. PubMed ID: 20207207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: the potential role of nutritional management.
    Leclercq IA; Horsmans Y
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):766-73. PubMed ID: 18827582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.